Naviter Wealth’s GSK GSK Stock Holding History

Naviter Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.93M	Buy	55,331 +11,577	+26%	+$612K	0.27%	86
2026 Q1	$2.44M	Buy	43,754 +1,682	+4%	+$91.1K	0.3%	81
2025 Q4	$2.08M	Sell	42,072 -8,253	-16%	-$385K	0.27%	88
2025 Q3	$2.19M	Buy	50,325 +1,473	+3%	+$57.5K	0.26%	99
2025 Q2	$1.9M	Buy	48,852 +2,178	+5%	+$83.2K	0.23%	115
2025 Q1	$1.83M	Sell	46,674 -990	-2%	-$36.2K	0.22%	125
2024 Q4	$1.63M	Buy	47,664 +244	+0.5%	+$8.78K	0.2%	133
2024 Q3	$1.96M	Sell	47,420 -241	-0.5%	-$9.86K	0.27%	108
2024 Q2	$1.85M	Buy	47,661 +3,742	+9%	+$157K	0.28%	106
2024 Q1	$1.9M	Sell	43,919 -829	-2%	-$34.2K	0.31%	91
2023 Q4	$1.67M	Buy	44,748 +10,171	+29%	+$365K	0.34%	82
2023 Q3	$1.27M	Buy	34,577 +2,312	+7%	+$82.1K	0.31%	81
2023 Q2	$1.16M	Buy	32,265 +3,348	+12%	+$120K	0.3%	88
2023 Q1	$1.04M	Sell	28,917 -4,918	-15%	-$172K	0.36%	79
2022 Q4	$1.17M	Buy	33,835 +3,182	+10%	+$106K	0.32%	77
2022 Q3	$906K	Buy	30,653 +11,543	+60%	+$437K	0.37%	58
2022 Q2	$1.04M	Buy	+19,110	New	+$1.05M	0.43%	49

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Naviter Wealth's GSK Position: Q2 2026 in Review

Naviter Wealth increased its GSK (GSK) stake by 26% in Q2 2026, buying an estimated $612K and bringing the position to 55,331 shares worth $2.93M. The position accounts for 0.27% of the portfolio, ranked #86.

Naviter Wealth first reported a position in GSK in Q2 2022 and has held it in 17 quarters since. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Naviter Wealth held 55,331 shares of GSK worth $2.93M as of Q2 2026.
Naviter Wealth bought 11,577 GSK shares in Q2 2026, an estimated $612K.
GSK made up 0.27% of Naviter Wealth's portfolio in Q2 2026, its #86 holding.
Naviter Wealth first reported a position in GSK in Q2 2022 and has held it in 17 quarters since.
1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Naviter Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.